Fibroblast Growth Factor 10
"Fibroblast Growth Factor 10" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fibroblast growth factor that is a mitogen for KERATINOCYTES. It activates FIBROBLAST GROWTH FACTOR RECEPTOR 2B and is involved in LUNG and limb development.
| Descriptor ID |
D051526
|
| MeSH Number(s) |
D12.644.276.624.200 D12.776.467.624.200 D23.529.624.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibroblast Growth Factor 10".
Below are MeSH descriptors whose meaning is more specific than "Fibroblast Growth Factor 10".
This graph shows the total number of publications written about "Fibroblast Growth Factor 10" by people in this website by year, and whether "Fibroblast Growth Factor 10" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibroblast Growth Factor 10" by people in Profiles.
-
Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, Parish LC, Jensen JL, Steed DL. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. 2001 Sep-Oct; 9(5):347-52.
-
Mongiat M, Taylor K, Otto J, Aho S, Uitto J, Whitelock JM, Iozzo RV. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem. 2000 Mar 10; 275(10):7095-100.
-
Cui Y, Urschel JD, Petrelli NJ. The effect of keratinocyte growth factor-2 on esophagogastric anastomotic wound healing in rats. Int J Surg Investig. 1999; 1(4):307-9.
-
Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA, Iozzo RV. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest. 1998 Oct 15; 102(8):1599-608.